ULTRAVIOLET SPECTROPHOTOMETRIC METHOD DEVELOPMENT FOR ESTIMATION OF NEW ANTIVIRAL REPURPOSING DRUG FAVIPIRAVIR
DOI:
https://doi.org/10.22159/ajpcr.2021.v14i7.41966Keywords:
Favipiravir, Ultraviolet spectrophotometric method, Linearity, Relative standard deviationAbstract
Objective: A new, economical, precise, linear, sensitive, accurate, ultraviolet (UV) spectrophotometric method for the estimation of new antiviral repurposing drug favipiravir as there is no reported simple UV spectrophotometric method for estimation. The efforts were made for development and validation of favipiravir as per ICH guidelines, because drug has a wide scope for formulations to be developed for treating different viruses.
Methods: This method was developed using ethanol and water as a solvent. Favipiravir showed the absorption maxima at 234 nm. A Shimadzu UV–visible spectrophotometer (UV JAPAN 1801) was used to carry out spectral analysis.
Results: The developed method was linear for a range of 0–10 μg/ml and displayed a good correlation coefficient of 0.9995. Accuracy of the method was estimated using a recovery study. The amount of drug recovered was found to be in the range of 99.30–99.91%. The % relative standard deviation value of intraday precision was found to be 0.408% and interday precision was found to be in the range of 0.348–0.693%. The % relative standard deviation found to be <2 which are indicative of the precision and reproducibility of the method. Detection limit and quantitation limit were noticed as 0.095 and 0.290, respectively.
Conclusion: The developed UV spectrophotometric method was validated statistically for linearity, accuracy, precision, and sensitivity and results proved that the method can be employed for routine analysis of favipiravir.
Downloads
References
Joshi S, Prakar J, Ansari A, Vora A, Talwar D, Tiwaskar M, et al. Role of favipiravir in the treatment of COVID. Int J Infect Dis 2021;102:501-8. DOI: https://doi.org/10.1016/j.ijid.2020.10.069
Haque SK, Elzagheid M. Antiviral drugs for influenza viruses. Int J Pharm Pharm Sci 2019;11:1-10. DOI: https://doi.org/10.22159/ijpps.2019v11i5.32024
Jyothi BJ, Padmaja G. UV spectrophotometric method for estimation of new drug, daclatasvir dihydrochloride. Int Res J Pharm 2016;7:484-8.
Bhaskar Reddy CM, Subba Reddy GV. A validated UV spectrophotometric determination of an antiviral drug zanamivir from tablet formulations. J Chem Pharm Res 2018;4:3624-7.
Ashour HK, Balel TS. New simple spectroscopic method for determination of the antiviral mixture of emtricitabine and tenofovir disoproxil fumarate. Arab J Chem 2017;10:1741-7. DOI: https://doi.org/10.1016/j.arabjc.2013.06.024
Deepali G, Elvis M. UV Spectrophotometric method for assay of the anti-retroviral agent lamivudine in active pharmaceutical ingredient and in its tablet formulation. J Young Pharm 2010;2:417-9. DOI: https://doi.org/10.4103/0975-1483.71628
Pokala RK, Kumari K, Bollikala HK. UV spectrophotometry method development and validation of sulfadiazine and trimethoprim in combined dosage form. Int J Pharm Pharm Sci 2017;10:103-7. DOI: https://doi.org/10.22159/ijpps.2018v10i1.21767
Yanjane SA, Ghurghure SM, Matole VK. UV spectrophotometric analysis and validation of oseltamivir phosphate in pure and pharmaceutical formulation. Int J Curr Pharm Res 2020;12:111-4. DOI: https://doi.org/10.22159/ijcpr.2020v12i2.37505
Sahu SA, Acharya SA, Chourasia AK, Asati AP. Method development and validation of oseltamivir phosphate in bulk drug by UV spectroscopy. Int J Pharm Pharm Sci 2012;4:194-6.
Prasanna NL, Rajitha K, Vasundhara G. A rapid and costeffective UV Spectrophotometric method development and validation for the quantitative estimation of indinavir sulphate in capsules. Int J Pharm Pharm Sci 2014;6:504-7.
Published
How to Cite
Issue
Section
Copyright (c) 2021 VENKATA KAVYA RENISETTY, Jeevana Jyothi B
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.